These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6531414)

  • 41. Dosimetry of normally and obliquely incident cobalt-60 teletherapy beams.
    Sabuwala HA
    Strahlentherapie; 1979 Nov; 155(11):766-9. PubMed ID: 516098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes of visual field and visual evoked potential in nasopharyngeal carcinoma patients after radiotherapy].
    Pan Y; Hu WH; Gao Y; Yu MZ; Huang SZ
    Ai Zheng; 2005 Jun; 24(6):722-6. PubMed ID: 15946488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative post-radiological studies of bone marrow following 200 kV and tele-cobalt therapy].
    Choné B
    Strahlentherapie Sonderb; 1965; 61():277-87. PubMed ID: 5890041
    [No Abstract]   [Full Text] [Related]  

  • 44. [Analysis of prognostic factors in 106 cases of carcinoma of the rhinopharynx treated with cobalt teletherapy].
    Zini G; Alberti G; Armaroli L; Barbieri E; Di Marzio G; Frezza G; Neri S; Silvano M; Babini L
    Radiol Med; 1989 Nov; 78(5):430-4. PubMed ID: 2608930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cobalt 60 radiotherapy of nasopharyngeal tumors 1963-1969].
    Kutzner J; Bornhofen B; Roesler A
    Strahlentherapie Sonderb; 1984; 78():79-82. PubMed ID: 6729910
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparison of absorbed doses from cobalt irradiation sources].
    Wagner R; Novotný J; Jirousek P; Kovár I; Horáková I
    Cesk Radiol; 1989 Aug; 43(4):267-72. PubMed ID: 2791123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Quantitative and qualitative changes of bone marrow following partial body irradiation in dependence on dose and time].
    Hoelzer D; Fliedner TM
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:26-8. PubMed ID: 4344557
    [No Abstract]   [Full Text] [Related]  

  • 48. [Characteristics of thermoluminescent dosimeters for the brehmsstrahlung and electron radiation of the betatron B5M-25].
    Popov VI; Motriĭ NIa
    Med Radiol (Mosk); 1983 Mar; 28(3):49-55. PubMed ID: 6403800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
    Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD
    J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma).
    Cox JD; Koehl RH; Turner WM; King FM
    Radiology; 1974 Jul; 112(1):179-85. PubMed ID: 4208964
    [No Abstract]   [Full Text] [Related]  

  • 51. IAEA-WHO cobalt-60 teletherapy dosimetry service using mailed LiF dosemeters. A survey of results obtaining during 1970-75.
    Eisenlohr HH; Jayaraman S
    Phys Med Biol; 1977 Jan; 22(1):18-28. PubMed ID: 840894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nasopharyngeal neoplasms: results following telecobalt therapy].
    Bohndorf W; Kamski W
    Strahlentherapie; 1973 Oct; 146(4):377-83. PubMed ID: 4786464
    [No Abstract]   [Full Text] [Related]  

  • 53. Radiation-induced sarcoma of the thyroid.
    Griem KL; Robb PK; Caldarelli DD; Templeton AC
    Arch Otolaryngol Head Neck Surg; 1989 Aug; 115(8):991-3. PubMed ID: 2751862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Focal dose determination using thermoluminescent dosimetry in telecobalt irradiation of bladder carcinoma].
    Niklander S
    Strahlentherapie; 1971 Jul; 142(1):64-7. PubMed ID: 5116425
    [No Abstract]   [Full Text] [Related]  

  • 55. Radiotherapy for pure seminoma of the testis.
    Doornbos JF; Hussey DH; Johnson DE
    Radiology; 1975 Aug; 116(02):401-4. PubMed ID: 1171506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute reaction and late damage of the normal tissue in cancer patients given a dynamic dose-fractionation under breathing of oxygen.
    Siracká E; Durkovský J; Jancina J; Révész L
    Neoplasma; 1973; 20(6):643-53. PubMed ID: 4773312
    [No Abstract]   [Full Text] [Related]  

  • 58. [Radiation therapy of the nasopharyngeal carcinoma: results of treatment and criteria of optimization (author's transl)].
    Frommhold H; Leipner N; Herberhold C
    Strahlentherapie; 1979 Jul; 155(7):441-50. PubMed ID: 115118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone marrow dose in chest radiography: the posteroanterior vs. anteroposterior projection.
    Archer BR; Whitmore RC; North LB; Bushong SC
    Radiology; 1979 Oct; 133(1):211-6. PubMed ID: 472293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.